Detection of adenosine receptor antagonists in rat brain using a modified radioreceptor assay

Journal of Neuroscience Methods

Volumn 77, Issue 2, 1997, Pages 135-142

  Finlayson, Keith ^a   Butcher, Steven P ^a   Sharkey, John ^a   Olverman, Henry J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adenosine receptor antagonist; Radioreceptor assay; Rat brain

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; DIAGNOSTIC VALUE; DRUG BRAIN LEVEL; DRUG PENETRATION; DRUG RECEPTOR BINDING; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; BRAIN CHEMISTRY; MALE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; THEOPHYLLINE;

EID: 0031425687     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(97)00118-0     Document Type: Article

References (25)

1. Barber A, Bartoszyk GD, Greiner HE, Mauler F, Murray RD, Seyfried CA, Simon M, Gottschlich R, Harting J, Lues I. Central and peripheral actions of the novel k-opioid receptor agonist, EMD 60400. Br J Pharmacol 1994;111:843-51.
2. 3 receptor antagonist. Eur J Pharmacol 1993; 250:147-52.
3. Baumgold J, Nikodijevic O, Jacobson KA. Penetration of adenosine antagonists into mouse brain as determined by ex-vivo binding. Biochem Pharmacol 1992;43:889-94.
4. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein dye binding. Anal Biochem 1976;72:710-6.
5. 1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 1987;335:59-63.
6. Burki HR. Binding of psychoactive drugs to rat brain amine receptors, measured ex-vivo, and their effects on the metabolism of biogenic amines. Naunyn-Schmiedeberg's Arch Pharmacol 1986;332:258-66.
7. Bymaster FP, Heath I, Hendrix JC, Shanon HE. Comparative behavioural and neurochemical activities of cholinergic antagonists in rats. J Pharmacol Exp Ther 1993a;267:16-24.
8. 1 muscarinic agonist xanomeline (LY246708/NNC11-0232). J Pharmacol Exp Ther 1993b;269:282-9.
9. Enna SJ. Radioreceptor assay techniques for neurotransmitter drugs. In: Yamamura HI, Enna SJ, Kuhar MJ, editors. Neurotransmitter Receptor Binding. New York: Raven Press, 1978:127-141.
10. Enna SJ, Snyder SH. A simple, sensitive and specific radioreceptor assay for endogenous GABA in brain tissue. J Neurochem 1976;26:221-4.
11. Freedman SB, Harley EA, Patel S. Direct measurement of muscarinic agents in the central nervous system of mice using ex-vivo binding. Eur J Pharmacol 1989;174:253-60.
12. Gould RJ, Murphy KMM, Snyder SH. A simple sensitive radioreceptor assay for calcium antagonist drugs. Life Sci 1983;33:2665-72.
13. Heffez DS, Nowak TS, Passonneau JV. Nimodipine levels in gerbil brain following parenteral drug administration. J Neurosurg 1985;63:589-92.
14. 1 receptors (ex-vivo radioreceptor binding studies). J Neural Transm 1992;89:61-9.
15. Janis RA, Krol GJ, Noe AJ, Pan M. Radioreceptor and high-performance liquid chromatographic assays for the calcium channel antagonist nitrendipine in serum. J Clin Pharmacol 1983;23:266-73.
16. 1 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 1987;336:204-10.
17. Marshall FA, Clark SA, Michel AD, Barnes JC. Binding of angiotensin antagonists to rat liver and brain membranes measured ex-vivo. Br J Pharmacol 1993;109:760-4.
18. 2 receptor directed drugs using a behavioural index. Br J Pharmacol 1994;113:110P.
19. 2 selective adenosine agonists and antagonists: Evidence for synergism and antagonism. J Pharmacol Exp Ther 1991;259:286-94.
20. B receptor antagonists by ex-vivo binding. Eur J Pharmacol 1994a;253:237-44.
21. Patel S, Smith AJ, Chapman KL, Fletcher AE, Kemp JA, Marshall GR, Hargreaves RJ, Ryecroft W, Iversen LL, Iversen SD, Baker R, Showell GA, Bourrain S, Neduvelil JG, Mattassa VG, Freedman SB. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in-vitro and high potency in-vivo. Mol Pharmacol 1994b;46:943-8.
22. Richards ML, Sadee W. In-vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex-vivo labelling method. Eur J Pharmacol 1985;114:343-53.
23. Sethy VH, Francis JW. Regulation of brain acetylcholine concentration by muscarinic receptors. J Pharmacol Exp Ther 1988;246:243-8.
24. 3 receptors by thioperamide and (R)-alpha-methylhistamine measured using histamine turnover and an ex-vivo labelling technique. Biochem Pharmacol 1992;44:1261-7.
25. Watson WP, Misra A, Cross AJ, Green AR, Little HJ. The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex-vivo and the ethanol withdrawal syndrome in mice. Br J Pharmacol 1994;112:1017-24.